Category: Today’s Highlights
Incyte and Lilly: Conquering Rheumatoid Arthritis
At the Annual European Congress of Rheumatology (EULAR 2016) in London, Eli Lilly and Company (LLY) and Incyte (INCY) presented data from RA-BEYOND study, demonstrating that their drug baricitinib was superior to placebo at inhibiting progressive radiographic joint damage in...
Read More
October 18, 2016
0
Vertex has good news from Australia. Why selling solid firms stocks.
Vertex Pharmaceuticals (VRTX) announced that the Pharmaceutical Benefits Advisory Committee’s (PBAC) in Australia recommendation the listing of Orkambi ® (lumacaftor/ivacaftor) on the Pharmaceutical Benefits Scheme (PBS). The recommendation is for cystic fibrosis people ages six and over who have two...
Read More
August 21, 2018
0
Ophthotech Bad News Adds to Regeneron Good News
Today we have good news and bad news. The good news is coming from Regeneron (REGN) through two sources: The first is the European Medicines Agency accepting Regeneron’s and Sanofi’s (SNY) Filing for the approval of Dupixent (dupilumab) for moderate to...
Read More
December 12, 2016
0
Starting the gene therapy chapter in the book of the biotech revolution
WE ARE LIVING AN HISTORIC BIOLOGICAL REVOLUTION . Unfortunately, the undeniably outstanding news has not yet penetrated the ears of many investors. They are still falling victim to the stock market traders’ games and to critics’ and bloggers’ magnifications or...
Read More
August 22, 2018
0
Bellicum Is Outperforming and So Should Be Its Stock
Bellicum Pharmaceuticals (BLCM) announced results from the BP-004 multicenter clinical trial for children with Primary Immune Deficiencies (PIDs) and hemoglobinopathies. The candidates received an add-back of Bellicum’s BPX-501 modified T cells following a haploidentical, T cell-depleted hematopoietic stem cell transplant...
Read More
December 5, 2016
0
It Is All About Array Biopharma
Prohost Biotech On ARRAY PHARMACEUTICALS Under the title “ Halozyme has Good News and Array Too”, we wrote the following about Array On Nov. 5, 2015. Array’s (ARRY) internal, broad based drug discovery and research technological capabilities is behind the creation...
Read More
November 22, 2016
0
About Portola
Portola (PTLA) has two important approved breakthrough products and an investigational product having promising results on very difficult-to-treat cancers . Instead of soaring following the approval of its two drugs and the good results coming from the investigational third drug,...
Read More
August 27, 2018
0
Ionis, the FDA and the exaggerated selloff of the firm's stock
A complete response letter (CRL) sent by The Division of Metabolism and Endocrinology Products of the United States’ FDA to Ionis Pharmaceuticals (IONS) and its affiliate Akcea Therapeutics (AKCA) regarding Waylivra™ (volanesorsen) carried like usual bad news. The FDA has...
Read More
August 30, 2018
0
An Early FDA Approval of Vertex’s Cystic Fibrosis Combo Symdeko
Expected or not, we believe that the news announcing that the U.S. Food and Drug Administration (FDA) approval Vertex’s (VRTX) cystic fibrosis combo product Symdeko ™ (tezacaftor/ivacaftor and ivacaftor) is good news. It is indeed excellent news for the many...
Read More
February 15, 2018
0
From Stanford: A Step on the Road Toward a Cancer Cure. From Theravance: a Worthwhile Co-Development Agreement with Janssen Biotech
A Stanford research team investigating a new immunotherapy approach, which consists of injecting tiny amounts of two immuno-stimulating molecules directly into the cancers themselves, announced good news. The first of the two injections contained a CpG oligonucleotide a short stretch...
Read More
February 7, 2018
0
Search ProhostBiotech
Popular Links
23andMe Holding Co (ME)Abbott Laboratories (ABT)AbbVie Inc (ABBV)AbCelleraAbeona Therapeutics (ABEO)Ablynx (ABLX)AbVitro IncAcadia (ACAD)Acceleron Pharma (XLRN)AcelRx Pharmaceuticals (ACRX).Acorda Therapeutics Inc (ACOR)Acumen Pharmaceuticals (ABOS)AdaptImmune Therapeutics (ADAP)Adaptive BiotechnologiesADC Therapeutics (ADCT)Adimab LLCAdvanced Micro Devices (AMD)Advaxis (ADXS)Adverum Biotechnologies (ADVM)Aerie Pharmaceuticals (AERI)AgenTus TherapeuticsAgenus (AGEN)AgeX Therapeutics (AGE)Agilent Technologies (A)Agilis Biotherapeutics IncAgios Pharmaceuticals (AGIO)AIM ImmunoTech (AIM)Aimmune Therapeutics (AIMT)Akari Therapeutics (AKTX)Akashi TherapeuticsAkcea Therapeutics (AKCA)Akebia Therapeutics Inc (AKBA)Akero Therapeutics (AKRO)Akous Inc (a wholly owned subsidiary of Eli Lilly Company)Alder BioPharmaceuticals (ALDR)Alexion Pharmaceuticals (ALXN)Alkermes (ALKS)Allergan Plc (AGN)Allogene TherapeuticsAllogene Therapeutics (ALLO)